Moderna CEO says fourth COVID-19 dose may be needed next fall
Jan 07, 2022
Governments, including the United Kingdom and South Korea, already are ordering the doses in preparation.
Long-haul COVID-19 may affect two of three with mild, moderate disease
Aug 20, 2021
“This is a real wake-up call for anyone who has not been vaccinated,” Melanie L. Bell, Ph.D., said in a statement. “If you get COVID, the chances that you’ll experience long-term...
mRNA vaccine effectiveness sustained over 24-week period
Aug 20, 2021
The Pfizer-BioNTech and Moderna vaccines were effective against COVID-19-associated hospitalizations among adults.
COVID-19 vaccines likely to become annual shots: White House
Sep 07, 2022
Future booster updates likely would target whatever omicron subvariant is spreading.
Third mRNA COVID-19 vaccine dose appears to be safe
Apr 15, 2022
There were higher reports of low-severity adverse effects but no change in severe events.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
Novavax COVID-19 vaccine shines in latest trial
Jun 14, 2021
The company says there were no cases of hospitalization or death among people who received the vaccine.
Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
Almost 140,000 COVID-19 deaths averted with vaccinations
Aug 19, 2021
The vaccination-associated reduction in deaths translated to statistical life benefit ranging from $625 billion to $1.4 trillion.
COVID-19 vaccination linked to lower risk for postinfection outcomes
Mar 13, 2024
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.